hemoregulatory peptide 5b has been researched along with tamoxifen in 1 studies
Studies (hemoregulatory peptide 5b) | Trials (hemoregulatory peptide 5b) | Recent Studies (post-2010) (hemoregulatory peptide 5b) | Studies (tamoxifen) | Trials (tamoxifen) | Recent Studies (post-2010) (tamoxifen) |
---|---|---|---|---|---|
43 | 0 | 2 | 20,630 | 2,227 | 6,256 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrés, ME; Araneda, S; Daza, C; Forray, MI; Gysling, K; Haeger, P | 1 |
1 other study(ies) available for hemoregulatory peptide 5b and tamoxifen
Article | Year |
---|---|
Estrogen receptors alpha and beta differentially regulate the transcriptional activity of the Urocortin gene.
Topics: Analysis of Variance; Animals; Corticotropin-Releasing Hormone; Dose-Response Relationship, Drug; Electrophoretic Mobility Shift Assay; Enzyme Activation; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Estrous Cycle; Female; Gene Expression Regulation; Hypothalamus; Immunohistochemistry; In Situ Hybridization; Male; Oligopeptides; Ovariectomy; PC12 Cells; Promoter Regions, Genetic; Protein Binding; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Tamoxifen; Transcription, Genetic; Transfection; Urocortins | 2006 |